NCT06694012 Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
| NCT ID | NCT06694012 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Osaka Metropolitan University |
| Condition | Type 2 Diabetes Mellitus (T2DM) |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2050-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-11-01 with a primary completion date of 2050-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and cardiovascular disease in a prospective cohort study of Japanese men and women. The investigators will also investigate novel risk factors for metabolic and cardiovascular disease using molecular weight-based metallomics analysis.
Eligibility Criteria
Inclusion Criteria: \- Exclusion Criteria: * Women who may be pregnant
Contact & Investigator
Tomoshige Hayashi, MD, PhD
PRINCIPAL INVESTIGATOR
Osaka Metropolitan University
Frequently Asked Questions
Who can join the NCT06694012 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Type 2 Diabetes Mellitus (T2DM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06694012 currently recruiting?
Yes, NCT06694012 is actively recruiting participants. Contact the research team at thayashi@omu.ac.jp for enrollment information.
Where is the NCT06694012 trial being conducted?
This trial is being conducted at Sakai, Japan.
Who is sponsoring the NCT06694012 clinical trial?
NCT06694012 is sponsored by Osaka Metropolitan University. The principal investigator is Tomoshige Hayashi, MD, PhD at Osaka Metropolitan University. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.